PFE
Pfizer Inc
28.70$
+0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 34.4% | 19.1% | 19.2% | 17.5% | 19.7% | 23.6% | 22.0% | 21.2% | 22.5% | 20.6% | 20.6% | 20.6% | |
| 1.5% | 1.3% | 0.3% | 0.5% | 0.5% | 0.5% | 0.7% | 0.8% | 0.6% | 0.5% | 0.8% | 0.5% | |
| 20.5% | 5.6% | 5.4% | 3.3% | 4.5% | 9.6% | 8.3% | 6.4% | 7.2% | 6.5% | 6.3% | 5.8% | |
| 7.0% | 4.9% | 5.0% | 7.0% | 8.1% | 6.9% | 7.1% | 7.8% | 8.7% | 7.6% | 6.1% | 6.2% | |
| 4.7% | 4.5% | 4.9% | 5.3% | 5.3% | 5.1% | 5.2% | 5.7% | 5.5% | 5.1% | 5.1% | 4.9% | |
| 8.3% | 9.7% | 8.5% | – | 8.4% | 8.6% | 8.8% | 9.1% | 9.0% | 9.3% | – | – | |
| 24.0% | 29.9% | 31.3% | 31.7% | 31.2% | 32.1% | 32.9% | 33.5% | 33.1% | 34.2% | 34.4% | 35.5% | |
| 18.7% | 28.7% | 28.4% | 28.3% | 27.3% | 26.0% | 25.9% | 25.6% | 24.6% | 25.8% | 25.3% | 23.4% | |
| 54.8% | 60.6% | 58.1% | 59.3% | 57.8% | 58.5% | 56.4% | 56.8% | 55.4% | 58.3% | 56.5% | 57.5% | |
| 14.5% | 21.1% | 18.3% | 20.3% | 19.7% | 20.1% | 17.5% | 18.3% | 17.5% | 17.8% | 16.5% | 16.2% | |
| 1.2% | 4.8% | 3.7% | 5.5% | 4.4% | 3.3% | 2.1% | 2.1% | 2.1% | 1.7% | 1.9% | 1.3% | |
| 2.5% | 3.0% | 2.5% | 2.4% | 2.4% | 2.6% | 2.5% | 2.5% | 2.4% | 2.5% | 2.2% | 2.3% | |
| 28.4% | 26.9% | 27.6% | 26.2% | 25.9% | 26.6% | 27.3% | 27.5% | 27.1% | 29.2% | 28.8% | 30.1% | |
| 45.1% | 39.3% | 41.7% | 40.6% | 42.0% | 41.3% | 43.4% | 43.0% | 44.5% | 41.5% | 43.4% | 42.4% | |
| 58.8% | 52.3% | 54.9% | 53.9% | 55.2% | 54.7% | 57.5% | 57.1% | 58.0% | 55.1% | 56.5% | 55.7% | |
| 2.6% | 2.5% | 2.6% | 2.6% | 2.6% | 2.7% | 2.7% | 2.8% | 2.7% | 2.7% | 2.8% | 2.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.